Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Getting Drugs through Small Pores: Exploiting the Porins Pathway in Pseudomonas aeruginosa.

Samanta S, Bodrenko I, Acosta-Gutiérrez S, D'Agostino T, Pathania M, Ghai I, Schleberger C, Bumann D, Wagner R, Winterhalter M, van den Berg B, Ceccarelli M.

ACS Infect Dis. 2018 Oct 12;4(10):1519-1528. doi: 10.1021/acsinfecdis.8b00149. Epub 2018 Aug 8.

PMID:
30039960
2.

Clonal analysis of Salmonella-specific effector T cells reveals serovar-specific and cross-reactive T cell responses.

Napolitani G, Kurupati P, Teng KWW, Gibani MM, Rei M, Aulicino A, Preciado-Llanes L, Wong MT, Becht E, Howson L, de Haas P, Salio M, Blohmke CJ, Olsen LR, Pinto DMS, Scifo L, Jones C, Dobinson H, Campbell D, Juel HB, Thomaides-Brears H, Pickard D, Bumann D, Baker S, Dougan G, Simmons A, Gordon MA, Newell EW, Pollard AJ, Cerundolo V.

Nat Immunol. 2018 Jul;19(7):742-754. doi: 10.1038/s41590-018-0133-z. Epub 2018 Jun 20.

PMID:
29925993
3.

The hepcidin-ferroportin axis controls the iron content of Salmonella-containing vacuoles in macrophages.

Lim D, Kim KS, Jeong JH, Marques O, Kim HJ, Song M, Lee TH, Kim JI, Choi HS, Min JJ, Bumann D, Muckenthaler MU, Choy HE.

Nat Commun. 2018 May 29;9(1):2091. doi: 10.1038/s41467-018-04446-8.

4.

TonB-Dependent Receptor Repertoire of Pseudomonas aeruginosa for Uptake of Siderophore-Drug Conjugates.

Luscher A, Moynié L, Auguste PS, Bumann D, Mazza L, Pletzer D, Naismith JH, Köhler T.

Antimicrob Agents Chemother. 2018 May 25;62(6). pii: e00097-18. doi: 10.1128/AAC.00097-18. Print 2018 Jun.

5.

Correction for Wu et al., "Salmonella Utilizes Zinc To Subvert Antimicrobial Host Defense of Macrophages via Modulation of NF-κB Signaling".

Wu A, Tymoszuk P, Haschka D, Heeke S, Dichtl S, Petzer V, Seifert M, Hilbe R, Sopper S, Talasz H, Bumann D, Lass-Flörl C, Theurl I, Zhang K, Weiss G.

Infect Immun. 2018 Feb 20;86(3). pii: e00881-17. doi: 10.1128/IAI.00881-17. Print 2018 Mar. No abstract available.

6.

Editorial overview: Bacterial systems biology.

Dehio C, Bumann D.

Curr Opin Microbiol. 2017 Oct;39:viii-xi. doi: 10.1016/j.mib.2017.11.024. No abstract available.

PMID:
29241558
7.

Structural basis for maintenance of bacterial outer membrane lipid asymmetry.

Abellón-Ruiz J, Kaptan SS, Baslé A, Claudi B, Bumann D, Kleinekathöfer U, van den Berg B.

Nat Microbiol. 2017 Dec;2(12):1616-1623. doi: 10.1038/s41564-017-0046-x. Epub 2017 Oct 16.

PMID:
29038444
8.

Heterogeneity of Salmonella-host interactions in infected host tissues.

Bumann D, Cunrath O.

Curr Opin Microbiol. 2017 Oct;39:57-63. doi: 10.1016/j.mib.2017.09.008. Epub 2017 Oct 6. Review.

PMID:
28988065
9.

Salmonella utilizes zinc to subvert anti-microbial host defense of macrophages via modulation of NF-κB signaling.

Wu A, Tymoszuk P, Haschka D, Heeke S, Dichtl S, Petzer V, Seifert M, Hilbe R, Sopper S, Talasz H, Bumann D, Lass-Flörl C, Theurl I, Zhang K, Weiss G.

Infect Immun. 2017 Sep 5. pii: IAI.00418-17. doi: 10.1128/IAI.00418-17. [Epub ahead of print] Erratum in: Infect Immun. 2018 Feb 20;86(3):.

10.

Intracellular Salmonella metabolism.

Bumann D, Schothorst J.

Cell Microbiol. 2017 Oct;19(10). doi: 10.1111/cmi.12766. Epub 2017 Aug 4. Review.

PMID:
28672057
11.

Myeloperoxidase targets oxidative host attacks to Salmonella and prevents collateral tissue damage.

Schürmann N, Forrer P, Casse O, Li J, Felmy B, Burgener AV, Ehrenfeuchter N, Hardt WD, Recher M, Hess C, Tschan-Plessl A, Khanna N, Bumann D.

Nat Microbiol. 2017 Jan 23;2:16268. doi: 10.1038/nmicrobiol.2016.268.

PMID:
28112722
12.

A Novel Genome-Editing Platform for Drug-Resistant Acinetobacter baumannii Reveals an AdeR-Unrelated Tigecycline Resistance Mechanism.

Trebosc V, Gartenmann S, Royet K, Manfredi P, Tötzl M, Schellhorn B, Pieren M, Tigges M, Lociuro S, Sennhenn PC, Gitzinger M, Bumann D, Kemmer C.

Antimicrob Agents Chemother. 2016 Nov 21;60(12):7263-7271. Print 2016 Dec.

13.
14.

Catechol siderophores repress the pyochelin pathway and activate the enterobactin pathway in Pseudomonas aeruginosa: an opportunity for siderophore-antibiotic conjugates development.

Gasser V, Baco E, Cunrath O, August PS, Perraud Q, Zill N, Schleberger C, Schmidt A, Paulen A, Bumann D, Mislin GL, Schalk IJ.

Environ Microbiol. 2016 Mar;18(3):819-32. doi: 10.1111/1462-2920.13199. Epub 2016 Feb 5.

PMID:
26718479
15.

Host Delivery of Favorite Meals for Intracellular Pathogens.

Abu Kwaik Y, Bumann D.

PLoS Pathog. 2015 Jun 25;11(6):e1004866. doi: 10.1371/journal.ppat.1004866. eCollection 2015 Jun. Review. No abstract available.

16.

Heterogeneous host-pathogen encounters: act locally, think globally.

Bumann D.

Cell Host Microbe. 2015 Jan 14;17(1):13-9. doi: 10.1016/j.chom.2014.12.006. Review.

17.

PLEKHM1 regulates Salmonella-containing vacuole biogenesis and infection.

McEwan DG, Richter B, Claudi B, Wigge C, Wild P, Farhan H, McGourty K, Coxon FP, Franz-Wachtel M, Perdu B, Akutsu M, Habermann A, Kirchof A, Helfrich MH, Odgren PR, Van Hul W, Frangakis AS, Rajalingam K, Macek B, Holden DW, Bumann D, Dikic I.

Cell Host Microbe. 2015 Jan 14;17(1):58-71. doi: 10.1016/j.chom.2014.11.011. Epub 2014 Dec 11.

18.

Fast sampling method for mammalian cell metabolic analyses using liquid chromatography-mass spectrometry.

Martano G, Delmotte N, Kiefer P, Christen P, Kentner D, Bumann D, Vorholt JA.

Nat Protoc. 2015 Jan;10(1):1-11. doi: 10.1038/nprot.2014.198. Epub 2014 Dec 4.

PMID:
25474028
19.

Identification of Protective Antigens for Vaccination against Systemic Salmonellosis.

Bumann D.

Front Immunol. 2014 Aug 11;5:381. doi: 10.3389/fimmu.2014.00381. eCollection 2014. Review.

20.

Phenotypic variation of Salmonella in host tissues delays eradication by antimicrobial chemotherapy.

Claudi B, Spröte P, Chirkova A, Personnic N, Zankl J, Schürmann N, Schmidt A, Bumann D.

Cell. 2014 Aug 14;158(4):722-733. doi: 10.1016/j.cell.2014.06.045.

21.

Shigella reroutes host cell central metabolism to obtain high-flux nutrient supply for vigorous intracellular growth.

Kentner D, Martano G, Callon M, Chiquet P, Brodmann M, Burton O, Wahlander A, Nanni P, Delmotte N, Grossmann J, Limenitakis J, Schlapbach R, Kiefer P, Vorholt JA, Hiller S, Bumann D.

Proc Natl Acad Sci U S A. 2014 Jul 8;111(27):9929-34. doi: 10.1073/pnas.1406694111. Epub 2014 Jun 23.

22.

The central metabolism regulator EIIAGlc switches Salmonella from growth arrest to acute virulence through activation of virulence factor secretion.

Mazé A, Glatter T, Bumann D.

Cell Rep. 2014 Jun 12;7(5):1426-1433. doi: 10.1016/j.celrep.2014.04.022. Epub 2014 May 15.

23.

Caspase-11 activation requires lysis of pathogen-containing vacuoles by IFN-induced GTPases.

Meunier E, Dick MS, Dreier RF, Schürmann N, Kenzelmann Broz D, Warming S, Roose-Girma M, Bumann D, Kayagaki N, Takeda K, Yamamoto M, Broz P.

Nature. 2014 May 15;509(7500):366-70. doi: 10.1038/nature13157. Epub 2014 Apr 16.

PMID:
24739961
24.

Disparate impact of oxidative host defenses determines the fate of Salmonella during systemic infection in mice.

Burton NA, Schürmann N, Casse O, Steeb AK, Claudi B, Zankl J, Schmidt A, Bumann D.

Cell Host Microbe. 2014 Jan 15;15(1):72-83. doi: 10.1016/j.chom.2013.12.006.

25.

Parallel exploitation of diverse host nutrients enhances Salmonella virulence.

Steeb B, Claudi B, Burton NA, Tienz P, Schmidt A, Farhan H, Mazé A, Bumann D.

PLoS Pathog. 2013;9(4):e1003301. doi: 10.1371/journal.ppat.1003301. Epub 2013 Apr 25.

26.

Microbial quest for food in vivo: 'nutritional virulence' as an emerging paradigm.

Abu Kwaik Y, Bumann D.

Cell Microbiol. 2013 Jun;15(6):882-90. doi: 10.1111/cmi.12138. Epub 2013 Apr 3. Review.

PMID:
23490329
27.

Functional identification of APIP as human mtnB, a key enzyme in the methionine salvage pathway.

Mary C, Duek P, Salleron L, Tienz P, Bumann D, Bairoch A, Lane L.

PLoS One. 2012;7(12):e52877. doi: 10.1371/journal.pone.0052877. Epub 2012 Dec 28.

28.

Immunity to intracellular Salmonella depends on surface-associated antigens.

Barat S, Willer Y, Rizos K, Claudi B, Mazé A, Schemmer AK, Kirchhoff D, Schmidt A, Burton N, Bumann D.

PLoS Pathog. 2012;8(10):e1002966. doi: 10.1371/journal.ppat.1002966. Epub 2012 Oct 18.

29.

Extensive in vivo resilience of persistent Salmonella.

Barat S, Steeb B, Mazé A, Bumann D.

PLoS One. 2012;7(7):e42007. doi: 10.1371/journal.pone.0042007. Epub 2012 Jul 24.

30.

Intestinal inflammation responds to microbial tissue load independent of pathogen/non-pathogen discrimination.

Willer Y, Müller B, Bumann D.

PLoS One. 2012;7(5):e35992. doi: 10.1371/journal.pone.0035992. Epub 2012 May 7.

31.

The initiative on Model Organism Proteomes (iMOP) Session September 6, 2011, Geneva, Switzerland.

Schrimpf SP, von Mering C, Bendixen E, Heazlewood JL, Bumann D, Omenn G, Hengartner MO.

Proteomics. 2012 Feb;12(3):346-50. doi: 10.1002/pmic.201290015.

32.

Identification of tumor-specific Salmonella Typhimurium promoters and their regulatory logic.

Leschner S, Deyneko IV, Lienenklaus S, Wolf K, Bloecker H, Bumann D, Loessner H, Weiss S.

Nucleic Acids Res. 2012 Apr;40(7):2984-94. doi: 10.1093/nar/gkr1041. Epub 2011 Dec 2.

33.

Salmonella-induced mucosal lectin RegIIIβ kills competing gut microbiota.

Stelter C, Käppeli R, König C, Krah A, Hardt WD, Stecher B, Bumann D.

PLoS One. 2011;6(6):e20749. doi: 10.1371/journal.pone.0020749. Epub 2011 Jun 9.

34.

Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth.

Wild P, Farhan H, McEwan DG, Wagner S, Rogov VV, Brady NR, Richter B, Korac J, Waidmann O, Choudhary C, Dötsch V, Bumann D, Dikic I.

Science. 2011 Jul 8;333(6039):228-33. doi: 10.1126/science.1205405. Epub 2011 May 26.

35.

Activation of a RhoA/myosin II-dependent but Arp2/3 complex-independent pathway facilitates Salmonella invasion.

Hänisch J, Kölm R, Wozniczka M, Bumann D, Rottner K, Stradal TE.

Cell Host Microbe. 2011 Apr 21;9(4):273-85. doi: 10.1016/j.chom.2011.03.009.

36.

Influence of infection route and virulence factors on colonization of solid tumors by Salmonella enterica serovar Typhimurium.

Crull K, Bumann D, Weiss S.

FEMS Immunol Med Microbiol. 2011 Jun;62(1):75-83. doi: 10.1111/j.1574-695X.2011.00790.x. Epub 2011 Mar 22.

37.

Kinetics of carbon sharing in a bacterial consortium revealed by combining stable isotope probing with fluorescence-activated cell sorting.

Pawelczyk S, Bumann D, Abraham WR.

J Appl Microbiol. 2011 Apr;110(4):1065-73. doi: 10.1111/j.1365-2672.2011.04964.x. Epub 2011 Feb 25.

38.

A community effort towards a knowledge-base and mathematical model of the human pathogen Salmonella Typhimurium LT2.

Thiele I, Hyduke DR, Steeb B, Fankam G, Allen DK, Bazzani S, Charusanti P, Chen FC, Fleming RM, Hsiung CA, De Keersmaecker SC, Liao YC, Marchal K, Mo ML, Özdemir E, Raghunathan A, Reed JL, Shin SI, Sigurbjörnsdóttir S, Steinmann J, Sudarsan S, Swainston N, Thijs IM, Zengler K, Palsson BO, Adkins JN, Bumann D.

BMC Syst Biol. 2011 Jan 18;5:8. doi: 10.1186/1752-0509-5-8.

39.

Pathogen proteomes during infection: A basis for infection research and novel control strategies.

Bumann D.

J Proteomics. 2010 Oct 10;73(11):2267-76. doi: 10.1016/j.jprot.2010.08.004. Epub 2010 Aug 24. Review.

PMID:
20797457
40.

Systemic, nasal and oral live vaccines against Pseudomonas aeruginosa: a clinical trial of immunogenicity in lower airways of human volunteers.

Bumann D, Behre C, Behre K, Herz S, Gewecke B, Gessner JE, von Specht BU, Baumann U.

Vaccine. 2010 Jan 8;28(3):707-13. doi: 10.1016/j.vaccine.2009.10.080. Epub 2009 Nov 1.

PMID:
19887136
41.

System-level analysis of Salmonella metabolism during infection.

Bumann D.

Curr Opin Microbiol. 2009 Oct;12(5):559-67. doi: 10.1016/j.mib.2009.08.004. Epub 2009 Sep 8. Review.

PMID:
19744878
42.

Molecular dissection of Salmonella-induced membrane ruffling versus invasion.

Hänisch J, Ehinger J, Ladwein M, Rohde M, Derivery E, Bosse T, Steffen A, Bumann D, Misselwitz B, Hardt WD, Gautreau A, Stradal TE, Rottner K.

Cell Microbiol. 2010 Jan;12(1):84-98. doi: 10.1111/j.1462-5822.2009.01380.x. Epub 2009 Sep 2.

PMID:
19732055
43.

Analysis of Cd14 as a genetic modifier of experimental inflammatory bowel disease (IBD) in mice.

de Buhr MF, Hedrich HJ, Westendorf AM, Obermeier F, Hofmann C, Zschemisch NH, Buer J, Bumann D, Goyert SM, Bleich A.

Inflamm Bowel Dis. 2009 Dec;15(12):1824-36. doi: 10.1002/ibd.21030. Epub 2009 Jul 27.

PMID:
19637338
44.

Has nature already identified all useful antibacterial targets?

Bumann D.

Curr Opin Microbiol. 2008 Oct;11(5):387-92. doi: 10.1016/j.mib.2008.08.002. Epub 2008 Oct 6. Review.

PMID:
18804175
45.

Correlation of T cell response and bacterial clearance in human volunteers challenged with Helicobacter pylori revealed by randomised controlled vaccination with Ty21a-based Salmonella vaccines.

Aebischer T, Bumann D, Epple HJ, Metzger W, Schneider T, Cherepnev G, Walduck AK, Kunkel D, Moos V, Loddenkemper C, Jiadze I, Panasyuk M, Stolte M, Graham DY, Zeitz M, Meyer TF.

Gut. 2008 Aug;57(8):1065-72. doi: 10.1136/gut.2007.145839. Epub 2008 Apr 16.

46.

FACS-isolation of Salmonella-infected cells with defined bacterial load from mouse spleen.

Thöne F, Schwanhäusser B, Becker D, Ballmaier M, Bumann D.

J Microbiol Methods. 2007 Dec;71(3):220-4. Epub 2007 Sep 11.

PMID:
17931727
47.

Identification and isolation of murine antigen-reactive T cells according to CD154 expression.

Kirchhoff D, Frentsch M, Leclerk P, Bumann D, Rausch S, Hartmann S, Thiel A, Scheffold A.

Eur J Immunol. 2007 Sep;37(9):2370-7.

48.
49.

Solitary intestinal lymphoid tissue provides a productive port of entry for Salmonella enterica serovar Typhimurium.

Halle S, Bumann D, Herbrand H, Willer Y, Dähne S, Förster R, Pabst O.

Infect Immun. 2007 Apr;75(4):1577-85. Epub 2007 Feb 5.

50.

Robust Salmonella metabolism limits possibilities for new antimicrobials.

Becker D, Selbach M, Rollenhagen C, Ballmaier M, Meyer TF, Mann M, Bumann D.

Nature. 2006 Mar 16;440(7082):303-7.

PMID:
16541065

Supplemental Content

Loading ...
Support Center